EJR IS INDEXED IN WEB OF SCIENCE AND PUBMED CENTRAL
European Journal of Rheumatology
  1. Home
  2. Coronavirus Disease-2019: Impl...
Short Communication

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus

Amr H. Sawalha 1 2 3 , Susan Manzi 4
1.

Division of Rheumatology, Department of Pediatrics, Children’s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

2.

Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

3.

Lupus Center of Excellence, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

4.

Autoimmunity Institute and Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania, USA

Eur J Rheumatol 2020; 7: Supplement S117-S120
DOI: 10.5152/eurjrheum.2020.20055
Keywords : COVID-19, cytokine storm, hydroxychloroquine, immunosuppression, lupus, SARS-CoV-2
Read: 4143 Downloads: 1650 Published: 08 April 2020
Volume 7, Issue 2, August 2020
Previous Article Next Article

Systemic lupus erythematosus is a chronic remitting-relapsing autoimmune disease that affects multiple organ systems. In this article we discuss aspects in the management of lupus patients that are particularly relevant during the current SARS-CoV-2 pandemic. We speculate that lupus patients might be more susceptible for a more severe COVID-19 disease course and emphasize the importance of maintaining remission in lupus patients. We discuss the critical role hydroxychloroquine plays in the management of lupus patients and suggest considering the psychosocial implications of the current pandemic on lupus care.

Cite this article as: Sawalha AH, Manzi S. Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus. Eur J Rheumatol 2020; 7(Suppl 2): S117-20.

Files
Full Text PDF  
EISSN 2148-4279